Drug-induced liver injury (DILI) is generally defined by elevated liver enzymes per DILIN (Drug-Induced Liver Injury Network) criteria (e.g., alanine aminotransferase (ALT) ≥5× ULN, alkaline phosphatase (ALP) ≥2× ULN, or total bilirubin ≥2.5 mg/dL) [8-12]. The gene discussed is GPT; the disease is drug-induced liver injury.